Joshua F Apgar

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Rheumatoid Arthritis

Sickle Cell Disease

Emergency Department

Top Venues

CPT: pharmacometrics & systems pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Sarah A Head, Carter Johnson, Saheli Sarkar, Andrew Matteson, Diana H Marcantonio, Fei Hua, John M Burke, Joshua F Apgar, David Flowers
Comparison of dose selection based on target engagement versus inhibition of receptor-ligand interaction for checkpoint inhibitors. CPT: pharmacometrics & systems pharmacology 13 (6) (2024)
Sarah A Head, Carter Johnson, Saheli Sarkar, Andrew Matteson, Diana H Marcantonio, Fei Hua, John M Burke, Joshua F Apgar, David Flowers
Comparison of dose selection based on target engagement versus inhibition of receptor-ligand interaction for checkpoint inhibitors. CPT: pharmacometrics & systems pharmacology 13 (6) (2024)
Sarah A Head, Carter Johnson, Saheli Sarkar, Andrew Matteson, Diana H Marcantonio, Fei Hua, John M Burke, Joshua F Apgar, David Flowers
Comparison of dose selection based on target engagement versus inhibition of receptor-ligand interaction for checkpoint inhibitors. CPT: pharmacometrics & systems pharmacology 13 (6) (2024)
Sarah A Head, Carter Johnson, Saheli Sarkar, Andrew Matteson, Diana H Marcantonio, Fei Hua, John M Burke, Joshua F Apgar, David Flowers
Comparison of dose selection based on target engagement versus inhibition of receptor-ligand interaction for checkpoint inhibitors. CPT: pharmacometrics & systems pharmacology (2024)
Yan Ji, Kumpal Madrasi, Deborah A Knee, Lore M Gruenbaum, Joshua F Apgar, John M Burke, Bruce Gomes
Quantitative systems pharmacology model of GITR-mediated T cell dynamics in tumor microenvironment. CPT: pharmacometrics & systems pharmacology (2023)
Yan Ji, Kumpal Madrasi, Deborah A Knee, Lore M Gruenbaum, Joshua F Apgar, John M Burke, Bruce Gomes
Quantitative systems pharmacology model of GITR-mediated T cell dynamics in tumor microenvironment. CPT: pharmacometrics & systems pharmacology 12 (3) (2023)
Yan Ji, Kumpal Madrasi, Deborah A Knee, Lore M Gruenbaum, Joshua F Apgar, John M Burke, Bruce Gomes
Quantitative systems pharmacology model of GITR-mediated T cell dynamics in tumor microenvironment. CPT: pharmacometrics & systems pharmacology 12 (3) (2023)
Yan Ji, Kumpal Madrasi, Deborah A Knee, Lore M Gruenbaum, Joshua F Apgar, John M Burke, Bruce Gomes
Quantitative Systems Pharmacology Model of GITR-mediated T cell dynamics in Tumor Microenvironment. CPT: pharmacometrics & systems pharmacology (2023)
Lin Lin, Fei Hua, Cristian Salinas, Carissa Young, Thierry Bussiere, Joshua F Apgar, John M Burke, Kumar Kandadi Muralidharan, Rajasimhan Rajagovindan, Ivan Nestorov
Quantitative systems pharmacology model for Alzheimer's disease to predict the effect of aducanumab on brain amyloid. CPT: pharmacometrics & systems pharmacology 11 (3) (2022)
Bo Zheng, Lucia Wille, Karsten Peppel, David Hagen, Andrew Matteson, Jeffrey Ahlers, James Schaff, Fei Hua, Theresa Yuraszeck, Enoch Cobbina, Joshua F Apgar, John M Burke, John Roberts, Raibatak Das
A systems pharmacology model for gene therapy in sickle cell disease. CPT: pharmacometrics & systems pharmacology 10 (7) (2021)